Catalyst Wire Dossier Catalyst Wire Dossier

Olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide

olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide · Slate Run Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, covering 2025-05-14 to 2025-05-14. Get the full timeline:

Most recent: FDA Approved: OLMESARTAN MEDOXOMIL AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE — Original Application (Slate Run Pharmaceuticals, LLC)

See pricing